交易 STAAR Surgical Co - STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.最新股票文章

Uber Technologies 股價預測:裁減 3,300 個職位,拓展機械人計程車業務
Uber 正進行重組,裁減約 3,300 個職位,同時在機械人計程車市場競爭加劇之際,擴大自動駕駛汽車合作關係。本文整理第三方對 UBER 的股價目標及技術分析。過往表現並非未來業績的可靠指標。
10:51, 2 10月 2026

微軟股價預測 | Azure 營收與財報分部調整
微軟是一家美國科技公司。2026 財年,Azure 營收達 1,019 億美元,公司亦宣布將於 2027 財年採用新的財報分部架構。了解第三方 MSFT 目標價及技術分析。過往表現並非未來業績的可靠指標。
14:37, 25 9月 2026

NVIDIA 股價預測 | 收購 Hugging Face
了解第三方對 NVIDIA 股價的預測,涵蓋技術分析、差價合約交易情緒、NVDA 股價歷史及 Capital.com 分析師觀點。
12:13, 25 9月 2026
Reuters News
